Health-related quality of life improvements in moderate to very severe chronic obstructive pulmonary disease patients on nebulized glycopyrrolate: evidence from the GOLDEN studies
The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)
Studies comparing medicationonly care to programs that combine GLP1 therapy with nutrition and behavioural support show better sustained weight loss, fewer side effects and less weight regain once the drug is stopped in the supported groups (Wilding et al., 2021)
By elevating growth hormone levels, Tesamorelin creates conditions where fat preferentially gets burned for energy while muscle tissue remains protected
GLP-1 receptor agonists, including semaglutide (sold as Ozempic and Wegovy), were originally developed to treat type 2 diabetes
The side effect profiles are distinct: metformin commonly causes gastrointestinal effects like diarrhea and nausea, while semaglutide may cause nausea during dose escalation and, rarely, pancreatitis or thyroid concerns